Imatinib and cardiac failure in idiopathic hypereosinophilic syndrome

Ann Hematol. 2010 Jul;89(7):745-6. doi: 10.1007/s00277-009-0866-8. Epub 2009 Dec 2.
No abstract available

Publication types

  • Letter

MeSH terms

  • Animals
  • Antineoplastic Agents / administration & dosage*
  • Antineoplastic Agents / adverse effects*
  • Benzamides
  • Echocardiography / methods
  • Electrocardiography / methods
  • Eosinophils
  • Female
  • Heart Failure / blood
  • Heart Failure / chemically induced*
  • Heart Failure / diagnostic imaging
  • Heart Failure / physiopathology
  • Humans
  • Hypereosinophilic Syndrome / blood
  • Hypereosinophilic Syndrome / diagnostic imaging
  • Hypereosinophilic Syndrome / drug therapy*
  • Hypereosinophilic Syndrome / physiopathology
  • Imatinib Mesylate
  • Leukocyte Count
  • Middle Aged
  • Piperazines / administration & dosage*
  • Piperazines / adverse effects*
  • Pyrimidines / administration & dosage*
  • Pyrimidines / adverse effects*
  • Troponin / blood

Substances

  • Antineoplastic Agents
  • Benzamides
  • Piperazines
  • Pyrimidines
  • Troponin
  • Imatinib Mesylate